Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
Agency: National Institutes of Health
- 93.279 -- Drug Use and Addiction Research Programs
Open opportunityLast Updated: Aug 31, 2026
Important dates
- Closing: June 16, 2028
Award details
- Expected project funding: Not specified
- Expected awards: Not specified
Award min.
Not specified
Award max.
Not specified
- Funding opportunity number:PAR-27-053
- Cost sharing or matching requirement:No
- Funding instrument type:
- Grant
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Health
- Category Explanation:Not specified
History
- Posted date: August 31, 2026
- Archive date: August 15, 2028
- Version: 1
Summary
Jump to documentsEligibility
Business
- For-profit organizations other than small businesses
- Small businesses
Education
- Private institutions of higher education
- Public and state institutions of higher education
- Independent school districts
Government
- Public and Indian housing authorities
- Special district governments
- City or township governments
- State governments
- Federally recognized Native American tribal governments
- County governments
Miscellaneous
- Other
Nonprofit
- Nonprofits non-higher education without 501(c)(3)
- Other Native American tribal organizations
- Nonprofits non-higher education with 501(c)(3)
Additional information on eligibility
Documents
| File name | Description | Last updated |
|---|---|---|
| PAR-27-053-Full-Announcement.html | PAR-27-053-Full-Announcement.html | Aug 31, 2026 03:47 PM UTC |
Agency contact information
Email: NIDA_DNB_BCNB_r61@nih.gov
NIDA_DNB_BCNB_r61@nih.gov
Link to additional information
No additional information is available
